Blood-filter treatment for chronic high-altitude sickness
Part of Lungs & breathing clinical trials.
This trial studies “erythrocytapheresis,” a procedure that filters part of the blood, to improve symptoms of chronic mountain sickness caused by long-term living at high altitude. It may help people with high-altitude–related headaches, dizziness, shortness of breath, poor sleep, fatigue, and related signs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old
- You live at high altitude (at least 2,500 meters) continuously for at least 1 year, with no recent travel to low altitude in the last 3 months
- Your blood test shows high hemoglobin (men ≥210 g/L, women ≥190 g/L) and you have mountain sickness symptoms or signs
- Your chronic mountain sickness symptom score is high enough (total score ≥6)
- You can sign consent (or a legal representative can)
- You have not had similar high-altitude blood treatments or specific medicines in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new ways to diagnose and treat severe altitude sickness, a serious condition that can develop when people climb too quickly to high elevations. It may help doctors identify and treat the condition faster, potentially preventing complications.
This trial tests whether high-flow oxygen (delivered through a special nasal tube) works better than standard oxygen therapy for a condition called high-altitude pulmonary edema (HAPE)—fluid buildup in the lungs caused by rapid ascent to high altitude. The study aims to see which approach helps patients breathe better and recover faster.
This trial tests whether a safe, non-invasive treatment called remote ischemic conditioning can help people living at high altitude who have developed thick blood (too many red blood cells). The treatment involves briefly reducing blood flow to the arm using a special cuff, which may help reduce excess red blood cell production.
This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.
This trial investigates whether a medication usually used for migraines (fremanezumab) can help prevent acute mountain sickness in healthy adults who travel to high altitudes. You would receive an injection and be monitored for symptoms.
This study looks at high-altitude polycythemia, a condition where your body makes too many red blood cells in response to living at high altitude. Researchers want to learn more about this condition and how to help people who have it.
Hear when a new Chronic Mountain Sickness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.